ABIM MOC Quiz

Question Title

* 1. Last Name

Question Title

* 2. First Name

Question Title

* 3. Title (MD, DO, RN)

Question Title

* 4. ABIM Number

Question Title

* 5. Month and Day of Birth (mm/dd)

By registering for MOC credit, you grant permission for your identifying data and evaluation results to be shared with the ACCME.

Question Title

* 6. All of the following are the most frequent symptoms in systemic AL Amyloidosis EXCEPT

Question Title

* 7. Localized Amyloidosis often involves bladder, skin, or airways and is usually treated locally or not treated at all; this is the following type

Question Title

* 8. Cardiac amyloidosis with heart failure with preserved ejection fraction (HFpEF) can be seen with AL and ATTR amyloidosis. Choose the only correct pair below

Question Title

* 9. In a patient presenting with systolic heart failure, the following are red flags that should prompt the clinician to consider amyloidosis EXCEPT

Question Title

* 10. In a patient with infiltrative cardiomyopathy by transthoracic ECHOcardiography and normal serum free light chain ratio, the next diagnostic step is

Question Title

* 11. Consider TTR genetic testing in peripheral neuropathy when any of the following EXCEPT:

Question Title

* 12. Which one of the following drugs is used to treat AL Amyloidosis?

Question Title

* 13. If you were to review ATTR patients with biopsy-proven cardiac amyloidosis, you would expect 25% to have an abnormal serum or urine protein electrophoresis and 10% to have an abnormal free light chain ratio.

Question Title

* 14. In patients with AL amyloid cardiomyopathy with recurrent cardiac syncope or non-sustained ventricular tachycardia (NSVT), an implantable cardioverter-defibrillator (ICD) should be placed if the patients are expected to survive more than one year and this is a good fit for Mayo Clinic cardiac involvement stages

Question Title

* 15. In patients with ATTR cardiomyopathy, please pick the INCORRECT match between the agent and the mechanism of action:

T